Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
FPH.NZ
STRONG BUYGet insider-trade alertsFisher & Paykel Healthcare Corporation Limited · Healthcare · New Zealand · $12.7B · Avg Vol: $13M/d
83
StockRankQ
83
V
22
M
68
P/E (TTM)
48.7x
ROE
23.4%
D/E
0.1x
Dividend %
1.3%
COMPANY DESCRIPTION
Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems in North America, Europe, the Asia Pacific, and internationally.
FINANCIAL SUMMARY (USD)
| Year | 2023 | 2024 | 2025 | 2026 | CAGR |
|---|---|---|---|---|---|
| Revenue | 896.1M | 991.8M | 722.2M | 1.3B | 13.3% |
| EPS | 0.24 | 0.13 | 0.36 | 0.45 | 22.6% |
| Shares | 579.2M | 584.0M | 583.5M | 587.3M | +1.4% |
| Debt | 82.2M | 106.7M | 86.5M | 82.4M | 0.1% |
| Equity | 989.1M | 992.3M | 1.1B | 1.2B | 6.5% |
| Op CF | — | — | — | — | — |
| Inv CF | -6.4M | -191.2M | -58.1M | -110.1M | — |
| Fin CF | -111.2M | -72.6M | -151.3M | -156.1M | — |
Loading...
PRICE (1Y)+17.0%
SMA 50SMA 200
Close
$21.69
RSI (14)
60.9
52W High
$23.15
From 52W High
0.9%
SCORE BREAKDOWN
Quality
83
ROIC
27.2%95.8
ROE
23.4%91.1
GP/Assets
49.9%87.2
Op. Margin
28.7%90.9
FCF/Assets
14.0%92.5
Piotroski
687.7
Int. Cover
50.0x88.5
D/E Ratio
0.07x71.6
Current Ratio
2.31x44.2
Value
22
P/E (TTM)
48.7x21.8
EV/EBITDA
29.3x18.9
P/FCF
54.7x22.6
P/B
10.7x10.1
P/S
9.8x26.2
Div Yield
1.3%33.3
Momentum
68
52W High %
94%89.4
RS 6M
3%76.7
SMA 50/200
0.98x57.1
EPS Rev 4W
—N/A
EPS Rev 12W
—N/A
EPS Improve
+36%46.5
Q Growth
14%56.5
FUNDAMENTALS
Market Cap
$12.7B
P/E (Forward)
35.8x
Gross Margin
63.7%
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of FPH.NZ are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| FPH.NZ | Fisher & Paykel Healthcare Corporation Limited(you) | $12.7B | 83 | STRONG BUY |
| AFT.NZ | AFT Pharmaceuticals Limited | $218M | 78 | BUY |
| RYM.NZ | Ryman Healthcare Limited | $1.3B | 25 | SELL |
| SUM.NZ | Summerset Group Holdings Limited | $1.2B | 28 | SELL |
| GXH.NZ | Green Cross Health Limited | $159M | 99 | STRONG BUY |
| ARX.AX | Aroa Biosurgery Limited | $141M | 59 | HOLD |
| RAD.NZ | Radius Residential Care Limited | $62M | 96 | STRONG BUY |
| OCA.NZ | Oceania Healthcare Limited | $304M | 37 | HOLD |
| PEB.NZ | Pacific Edge Limited | $210M | 29 | SELL |
Peer medians: ROE 8.3% · P/E 13.4x · Gross margin 12.2%